Interaction of baicalein and copper with α-synuclein: Electrochemical approach to Parkinson’s Disease

Parkinson’s Disease (PD) is a neurological disorder increasingly affecting the aging population worldwide. The presence of Lewy bodies is the cause of PD, where fibrillar α-synuclein is the major component. This report describes the electrochemical analysis of α-synuclein protein in the presence of factors that accelerate or inhibit the rate of its aggregation. Baicalein is an electro-active flavonoid that can act as a metal-chelator and form several products including quinones upon oxidation. Exposure to Cu(II) ions is known to cause significant acceleration in the rate of α-synuclein fibril formation. Square-wave voltammetry (SWV) of α-synuclein in the presence of these electro-active factors revealed distinct interfacial changes attributed to complex formation of α-synuclein with these species in vitro. The role of baicalein as a fibrillogenesis inhibitor was found to be most effective during the early stages of the fibril formation. The proof-of-principal results indicate that electrochemistry as a drug screening technique can provide a powerful tool for the discovery of new fibrillogenesis inhibitors as promising therapeutics for neurodegenerative diseases.